The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors.

Source:http://linkedlifedata.com/resource/pubmed/id/11309294

Cancer Res. 2001 Apr 15 61 8 3369-72

Download in:

View as

General Info

PMID
11309294